Achillion Pharmaceuticals, Inc. (ACHN)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.48 / 7.01
Exchange NASDAQ
Div & Yield N.A. (N.A)

From Our Partners

Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings?

Zacks

Apellis' (APLS) PNH Drug Betters Alexion's Soliris in Study

Zacks

4 Reasons Why Investors Should Buy Alexion (ALXN) in 2020

Zacks

Investors Dig Into Trade War Halt (Stocks To Watch Podcast)

SeekingAlpha

Stocks To Watch: Investors Dig Into Trade War Halt

SeekingAlpha

Piper Jaffray recommends Alexion following topline Phase 2 data

The Fly

Regeneron's pozelimab shows positive effect in PNH study

SeekingAlpha

Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH

Zacks

EMA grants PRIME designation to Achillion's danicopa

SeekingAlpha

EMA grants PRIME designation to Achillion's danicopan

SeekingAlpha

Alexion (ALXN) Up 10 % YTD on Soliris & Ultomiris Strength

Zacks

BioCryst: A New Actor In The Alternative Pathway Inhibition Field

SeekingAlpha

4 RNA Therapy Stocks For A Biotech Portfolio

SeekingAlpha

Achillion downgraded to Market Perform from Outperform at JMP Securities

The Fly

Achillion Pharmaceuticals EPS beats by $0.02

SeekingAlpha
Biotech Has Momentum

Biotech Has Momentum

Takeover news has the sector buzzing this morning.

Columnist Conversation

COLUMNIST TWEETS

REAL MONEY POST INDUSTRIAL AVERAGE